Your browser doesn't support javascript.
loading
Nine-year prostate cancer survival differences between aggressive versus conservative therapy in men with advanced and metastatic prostate cancer.
Dall'Era, Marc A; Lo, Mary J; Chen, Jaclyn; Cress, Rosemary; Hamilton, Ann S.
Affiliation
  • Dall'Era MA; Department of Urology, University of California at Davis Comprehensive Cancer Center, Sacramento, California.
  • Lo MJ; Department of Preventative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Chen J; Department of Urology, University of California at Davis Comprehensive Cancer Center, Sacramento, California.
  • Cress R; Public Health Institute, Cancer Registry of Greater California, Sacramento, California.
  • Hamilton AS; Department of Public Health Sciences, School of Medicine, University of California at Davis, Sacramento, California.
Cancer ; 124(9): 1921-1928, 2018 05 01.
Article in En | MEDLINE | ID: mdl-29499075
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatectomy / Prostatic Neoplasms / Antineoplastic Agents, Hormonal / Androgen Antagonists Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatectomy / Prostatic Neoplasms / Antineoplastic Agents, Hormonal / Androgen Antagonists Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Year: 2018 Type: Article